Skip to main content
Clinical Trials/JPRN-UMIN000030551
JPRN-UMIN000030551Completed未知

Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma - Phase I study of nab-paclitaxel and gemcitabine CRT for BR and UR-LA PDAC

Mie university0 sites15 target enrollmentStarted: December 25, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 85years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Patients with allergy for nab-paclitaxel and gemcitabine 2) Patients with severe infection 3) Patients who are considered to be inappropriate for this study

Investigators

Similar Trials